Vertex Pharmaceuticals (VRTX) P/S ratio

P/S ratio today
11.5×

Vertex Pharmaceuticals (VRTX) trades at 11.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 9.7×. That is 3.4% higher than the 9.4× of fiscal 2024. Figures as of 18 Nov 2026, 04:53 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
11.5×
P/S ratio, fiscal 2025
9.7×
Change on fiscal 2024
+3.4%
Highest on record
72.9×fiscal 2009
Lowest on record
4.9×fiscal 2011
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Vertex Pharmaceuticals P/S ratio, in more detail

Today's figure is 17.8% above the fiscal 2025 year-end.

Across the 18 fiscal year-ends on record (2008–2025), the highest was 72.9× in fiscal 2009 and the lowest 4.9× in fiscal 2011. Today's P/S ratio is higher than at 50% of the 18 fiscal year-ends on record; their median is 12.2×.

History · 18 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Vertex Pharmaceuticals P/S ratio, year by year

Vertex Pharmaceuticals (VRTX) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today11.5×—$534.20—
20259.7× 3.4% up$453.36$46.52
20249.4× 12.3% down$402.70$42.73
202310.7× 28.2% up$406.89$37.89
20228.4× 11.2% up$288.78$34.47
20217.5× 24.9% down$219.60$29.14
202010.0× 26.8% down$236.34$23.56
201913.7× 2.7% down$218.95$15.97
201814.1× 7.6% down$165.71$11.76
201715.2× 44.0% up$149.86$9.83
201610.6× 64.0% down$73.67$6.96
201529.4× 38.9% down$125.83$4.28
201448.2× 249.3% up$118.80$2.47
201313.8× 133.4% up$74.30$5.39
20125.9× 20.2% up$41.90$7.09
20114.9× 90.0% down$33.21$6.76
201049.0× 32.8% down$35.03$0.72
200972.9× 199.5% up$42.85$0.59
200824.3×—$30.38$1.25

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Vertex Pharmaceuticals and comparable companies
CompanyP/S ratio
Pfizer PFE2.6×
Danaher DHR6.5×
Intuitive Surgical ISRG14.8×
Vertex Pharmaceuticals VRTX11.3×
Medtronic MDT3.6×
Bristol-Myers Squibb BMY2.6×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on VRTX

Vertex Pharmaceuticals, figure by figure

Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecardAll health care companies by market value

Vertex Pharmaceuticals P/S ratio: questions and answers

What is Vertex Pharmaceuticals's P/S ratio?

Vertex Pharmaceuticals (VRTX) trades at 11.5× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 9.7×. That is 3.4% higher than the 9.4× of fiscal 2024.

Is Vertex Pharmaceuticals's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 50% of the 18 fiscal year-ends on record; their median is 12.2×.

What are the highest and lowest P/S ratio figures on record for Vertex Pharmaceuticals?

Across the 18 fiscal year-ends on record (2008–2025), the highest was 72.9× in fiscal 2009 and the lowest 4.9× in fiscal 2011.

How is Vertex Pharmaceuticals's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.